Simon Amy - Insider Non-Derivative Transactions at Beam Therapeutics Inc. (BEAM) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jul 2, 2024, Simon Amy's relationship to Beam Therapeutics Inc. (BEAM) is Officer (Chief Medical Officer), and currently has 68,805 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other BEAM insiders.

Data Source: SEC.
Simon Amy - Insider Non-Derivative Transactions of BEAM Common Stock
Simon Amy - Insider Non-Derivative Transactions at BEAM
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jul 3, 2024 Sell -- (Common Stock) 748 22.95 68805
Jul 2, 2024 Sell -- (Common Stock) 502 23.76 69553
Apr 3, 2024 Sell -- (Common Stock) 16530 30.54 70060
Apr 2, 2024 Sell -- (Common Stock) 7157 32.13 86590
Apr 1, 2024 Acquisition -- (Common Stock) 27500 0 93747
Oct 31, 2023 Sell -- (Common Stock) 3448 18.7 65469
Jul 11, 2023 Sell -- (Common Stock) 391 30.48 68917
Apr 5, 2023 Sell -- (Common Stock) 1161 29.09 69308
Apr 5, 2023 Sell -- (Common Stock) 10493 29.77 70469
Apr 4, 2023 Sell -- (Common Stock) 4445 30.31 80962
Apr 1, 2023 Acquisition -- (Common Stock) 20000 0 85129